Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Larsson, EM; Sundén, P; Olsson, CG; Debatin, J; Duerinckx, AJ; Baum, R; Hahn, D; Ebner, F.
MR venography using an intravascular contrast agent: results from a multicenter phase 2 study of dosage.
AJR Am J Roentgenol. 2003; 180(1):227-232 Doi: 10.2214/ajr.180.1.1800227 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Ebner Franz
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
OBJECTIVE: The objective of this study was to determine the optimal dose of the iron oxide contrast agent feruglose for contrast-enhanced MR venography of the abdominopelvic and lower extremity veins and to evaluate its safety and tolerability in patients with deep venous thrombosis. SUBJECTS AND METHODS: We enrolled in our study a total of 45 patients at six centers who had lower extremity deep venous thrombosis documented on radiographic venography. Forty-four patients received the study drug; 39 completed the study. Each patient received three sequential IV injections of feruglose at doses of 0.75, 1.25, and 3.0 mg Fe/kg body weight. MR venography at 1.5 T was repeated at three levels after each dose. Safety was evaluated. RESULTS: The agreement between contrast-enhanced MR venography and radiographic venography with regard to deep venous thrombosis above the knee was zero at the lowest dose (0.75 mg Fe/kg body weight), 43% at the dose 2.0 mg Fe/kg body weight, and 49% at the dose 5.0 mg Fe/kg body weight. No significant difference was seen between the two highest doses. The highest cumulative dose provided the greatest diagnostic usefulness score. No serious adverse events occurred. CONCLUSION: The two highest doses of feruglose showed the best agreement between contrast-enhanced MR venography and radiographic venography for deep venous thrombosis above the knee. The safety and tolerability of feruglose were confirmed.
Find related publications in this database (using NLM MeSH Indexing)
Adult -
Aged -
Aged, 80 and over -
Contrast Media - administration and dosage
Female - administration and dosage
Humans - administration and dosage
Injections, Intravenous - administration and dosage
Iron - administration and dosage
Leg - blood supply
Magnetic Resonance Angiography - blood supply
Male - blood supply
Middle Aged - blood supply
Oxides - administration and dosage
Phlebography - administration and dosage
Sensitivity and Specificity - administration and dosage
Veins - pathology
Venous Thrombosis - diagnosis

© Med Uni GrazImprint